Learn about the risks and benefits of treatment, what you may expect and the importance of tracking your symptoms.
CLINICAL TRIAL RESULTS
The efficacy and safety of XELJANZ® (tofacitinib) were tested in 2 studies that involved adult patients with active psoriatic arthritis. Explore the results.
TRACKING YOUR SYMPTOMS
Recording your symptoms in the PsA Journal may be a useful tool to share with your doctor.
TIPS TO REMEMBER
Easy ways to help you remember to take XELJANZ as prescribed by your doctor.
TELL US MORE
The information you provide here will be used by Pfizer and parties acting on its behalf to develop or improve materials related to certain chronic inflammatory conditions and use of XELJANZ.
Title
What You Might Expect
indication
psa
poll
what-you-might-expect
Thank You
Thank you for taking the poll.
Submit
Submit
Submit Sending
One Moment Please
Staging
AEM-xeljanz_staging-psa-what-you-might-expect
Uat
AEM-xeljanz_uat-psa-what-you-might-expect
Prod
form_builder__production__641__wd